Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

University Health Network, Toronto · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
cisplatin
biliary tract carcinoma, gallbladder carcinoma, randomized, selumetinib, tablets, cisplatin, gemcitabine, non-resectable, recurrent, metstatic, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 885422
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.